Showing all 4 resultsSorted by popularity
Filter
Safinamide: A Plus for Parkinson’s Disease Management
Safinamide, a novel, selective MAO-B (Monoamine Oxidase-B) inhibitor, is specifically approved as an add-on therapy for Parkinson’s Disease. “OFF” times are commonly referred to as the periods during which standard medicines like Levodopa/Carbidopa fail to work effectively or their effect wears off. Safinamide helps bridge this therapeutic gap during “OFF” episodes, improving motor control and overall quality of life.
Mechanism of Action of Safinamide
Safinamide has a distinctive dual mechanism to manage neurological symptoms:
Dopaminergic Action: Safinamide selectively and reversibly inhibits MAO-B, the enzyme responsible for breaking down dopamine in the brain. This helps maintain dopamine levels for longer, reducing “OFF” time.
Non-Dopaminergic Action: It also modulates glutamate, an excitatory neurotransmitter, by blocking voltage-gated sodium channels, thereby reducing abnormal neuronal signaling linked to motor complications.
Major Advantages & Clinical Applications
Benefit | How it Helps
Reduced “OFF” Time — Decreases periods when Parkinsonian symptoms are uncontrolled
Improved “ON” Time — Enhances effective motor control with fewer fluctuations
Better Mobility — Improves coordination and ease of movement
Add-On Effect — Works synergistically with Levodopa to enhance treatment outcomes
Uses & Dosing Considerations
Specialist Supervision: Safinamide should be initiated and adjusted by a neurologist or an experienced physician in Parkinson’s Disease management.
Starting Dose: Typically begins at 50 mg once daily, which may be increased to 100 mg after about two weeks based on tolerance.
Administration: Take once daily at the same time with a full glass of water, with or without food.
Consistency: Regular use is essential to maintain stable drug levels and consistent motor control.
Missed Dose: Do not double doses. Simply take the next scheduled dose the following day.
Well-Known Issues
1. Is Safinamide an alternative to Levodopa?
No. Safinamide is used alongside Levodopa/Carbidopa to enhance its effectiveness and reduce motor fluctuations.
2. How quickly will I see improvement?
Many patients notice reduced “OFF” time within 2–4 weeks, though full benefits may take several months.
3. Are dietary restrictions (like tyramine-containing foods) required?
At recommended doses, Safinamide has minimal interaction with tyramine, so strict dietary restrictions (e.g., aged cheese, cured meats) are usually not necessary. Moderation is still advisable.
4. What are the common side effects?
Common effects include dyskinesia (involuntary movements), nausea, falls, and insomnia. Severe worsening of involuntary movements should be reported to a doctor.
5. Can Safinamide be taken with antidepressants?
Use caution. Combining with certain antidepressants may increase the risk of serotonin syndrome. Always inform your doctor about all medications and supplements.
6. Does Safinamide affect eyesight?
Rare retinal effects have been observed in some studies. Patients with retinal disease or visual symptoms should consult an ophthalmologist if any changes in vision occur.